Ngā hua rapu kaituhi

1

Immobilization of the early secretory pathway by a virus glycoprotein that binds to microtubules mā Aimin Xu

I whakaputaina 2000

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
2

Adipose Extracellular Vesicles in Intercellular and Inter-Organ Crosstalk in Metabolic Health and Diseases mā Zhe Huang, Aimin Xu

I whakaputaina 2021

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
3

Fibroblast Growth Factor 21 Protects against Atherosclerosis via Fine-Tuning the Multiorgan Crosstalk mā Leigang Jin, Zhuofeng Lin, Aimin Xu

I whakaputaina 2016

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
4

Obesity, Bone Loss, and Periodontitis: The Interlink mā Pengfei Zhao, Aimin Xu, WK Leung

I whakaputaina 2022

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
5

Expression of translationally controlled tumour protein is regulated by calcium at both the transcriptional and post-transcriptional level mā Aimin Xu, A. Richard BELLAMY, John A. TAYLOR

I whakaputaina 1999

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
6

Effects of an AMP-Activated Protein Kinase Inhibitor, Compound C, on Adipogenic Differentiation of 3T3-L1 Cells mā Ye Gao, Yi Zhou, Aimin Xu, Donghai Wu

I whakaputaina 2008

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
7

Neutrophils in type 1 diabetes mā Juan Huang, Yang Xiao, Aimin Xu, Zhiguang Zhou

I whakaputaina 2015

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
8

The Potential Role of Fibroblast Growth Factor 21 in Lipid Metabolism and Hypertension mā Zhe Huang, Aimin Xu, Bernard M.Y. Cheung

I whakaputaina 2017

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
9

Fibroblast Growth Factor–Based Pharmacotherapies for the Treatment of Obesity-Related Metabolic Complications mā Leigang Jin, Ranyao Yang, Leiluo Geng, Aimin Xu

I whakaputaina 2022

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
10

Hormone-based pharmacotherapy for metabolic dysfunction-associated fatty liver disease mā Zara Siu Wa Chui, Yaqian Xue, Aimin Xu

I whakaputaina 2024

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
11

Adiponectin and cardiovascular health: an update mā Xiaoyan Hui, Karen SL Lam, Paul M. Vanhoutte, Aimin Xu

I whakaputaina 2011

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
12

Protective roles of adiponectin in obesity-related fatty liver diseases: mechanisms and therapeutic implications mā Yu Wang, Mingyan Zhou, Karen S.L. Lam, Aimin Xu

I whakaputaina 2009

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
13

Obesity as the common soil of non‐alcoholic fatty liver disease and diabetes: Role of adipokines mā Elaine Hui, Aimin Xu, Hong Yang, Karen S.L. Lam

I whakaputaina 2013

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
14

The FGF21–adiponectin axis in controlling energy and vascular homeostasis mā Xiaoyan Hui, Tianshi Feng, Qing Liu, Yuan Gao, Aimin Xu

I whakaputaina 2016

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
15

Heterogeneity of white adipose tissue: molecular basis and clinical implications mā Kelvin H. M. Kwok, Karen S.L. Lam, Aimin Xu

I whakaputaina 2016

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
16

Thirty Years of Saying NO mā Paul M. Vanhoutte, Yingzi Zhao, Aimin Xu, Susan W.S. Leung

I whakaputaina 2016

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
17

Fibroblast Growth Factor 21 as an emerging metabolic regulator: clinical perspectives mā Yu Cho Woo, Aimin Xu, Yu Wang, Karen S.L. Lam

I whakaputaina 2012

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
18

Anti-inflammation Therapy by Activation of Prostaglandin EP4 Receptor in Cardiovascular and Other Inflammatory Diseases mā Eva H.C. Tang, Peter Libby, Paul M. Vanhoutte, Aimin Xu

I whakaputaina 2011

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
19

Lipocalin‐2—The myth of its expression and function mā Dahui Li, Wai Yan Sun, Bowen Fu, Aimin Xu, Yu Wang

I whakaputaina 2019

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
20

Piezo Ion Channels in Cardiovascular Mechanobiology mā Dominique Douguet, Amanda Patel, Aimin Xu, Paul M. Vanhoutte, Éric Honoré

I whakaputaina 2019

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:

Ngā hua rapu - Aimin Xu

Immobilization of the early secretory pathway by a virus glycoprotein that binds to microtubules mā Aimin Xu

Adipose Extracellular Vesicles in Intercellular and Inter-Organ Crosstalk in Metabolic Health and Diseases mā Zhe Huang, Aimin Xu

Fibroblast Growth Factor 21 Protects against Atherosclerosis via Fine-Tuning the Multiorgan Crosstalk mā Leigang Jin, Zhuofeng Lin, Aimin Xu

Obesity, Bone Loss, and Periodontitis: The Interlink mā Pengfei Zhao, Aimin Xu, WK Leung

Expression of translationally controlled tumour protein is regulated by calcium at both the transcriptional and post-transcriptional level mā Aimin Xu, A. Richard BELLAMY, John A. TAYLOR

Effects of an AMP-Activated Protein Kinase Inhibitor, Compound C, on Adipogenic Differentiation of 3T3-L1 Cells mā Ye Gao, Yi Zhou, Aimin Xu, Donghai Wu

Neutrophils in type 1 diabetes mā Juan Huang, Yang Xiao, Aimin Xu, Zhiguang Zhou

The Potential Role of Fibroblast Growth Factor 21 in Lipid Metabolism and Hypertension mā Zhe Huang, Aimin Xu, Bernard M.Y. Cheung

Fibroblast Growth Factor–Based Pharmacotherapies for the Treatment of Obesity-Related Metabolic Complications mā Leigang Jin, Ranyao Yang, Leiluo Geng, Aimin Xu

Hormone-based pharmacotherapy for metabolic dysfunction-associated fatty liver disease mā Zara Siu Wa Chui, Yaqian Xue, Aimin Xu

Adiponectin and cardiovascular health: an update mā Xiaoyan Hui, Karen SL Lam, Paul M. Vanhoutte, Aimin Xu

Protective roles of adiponectin in obesity-related fatty liver diseases: mechanisms and therapeutic implications mā Yu Wang, Mingyan Zhou, Karen S.L. Lam, Aimin Xu

Obesity as the common soil of non‐alcoholic fatty liver disease and diabetes: Role of adipokines mā Elaine Hui, Aimin Xu, Hong Yang, Karen S.L. Lam

The FGF21–adiponectin axis in controlling energy and vascular homeostasis mā Xiaoyan Hui, Tianshi Feng, Qing Liu, Yuan Gao, Aimin Xu

Heterogeneity of white adipose tissue: molecular basis and clinical implications mā Kelvin H. M. Kwok, Karen S.L. Lam, Aimin Xu

Thirty Years of Saying NO mā Paul M. Vanhoutte, Yingzi Zhao, Aimin Xu, Susan W.S. Leung

Fibroblast Growth Factor 21 as an emerging metabolic regulator: clinical perspectives mā Yu Cho Woo, Aimin Xu, Yu Wang, Karen S.L. Lam

Anti-inflammation Therapy by Activation of Prostaglandin EP4 Receptor in Cardiovascular and Other Inflammatory Diseases mā Eva H.C. Tang, Peter Libby, Paul M. Vanhoutte, Aimin Xu

Lipocalin‐2—The myth of its expression and function mā Dahui Li, Wai Yan Sun, Bowen Fu, Aimin Xu, Yu Wang

Piezo Ion Channels in Cardiovascular Mechanobiology mā Dominique Douguet, Amanda Patel, Aimin Xu, Paul M. Vanhoutte, Éric Honoré

Ngā utauta rapu:

Ngā marau whai pānga